Ping An Good Doctor deepens AI-assisted care, expands hospital and pharmacy network
Ping An Good Doctor's AI Doctor service reached 100% retail coverage and 9.7 million users in H1 2026, the company said.
AI
The age of AI: when scientific discovery becomes collaborative
The age of collaborative science should not be defined by how much reasoning machines can perform, argues HealthTechAsia's Vishnu Narayan.
Ant Group upgrades physician platform into AI workstation for millions of doctors
Two AI capabilities sit at the centre of the platform: an AI Medical Assistant for clinical decision support, and an AI Doctor Agent that individual physicians can configure for patient…
Malaysia’s AI Nation 2030 plan designates healthcare as priority “Impact Engine”
Malaysia has announced AI Malaysia Berhad, formalising and expanding the National AI Office, and Malaysia AI Safety Institute, intended to strengthen technical capacity.
Thailand opens public consultation on draft AI Act
Oversight would be decentralised, with sector regulators - in health, for example - responsible for AI within their own industries, coordinated by a national AI steering committee.
Laos holds first high-level policy dialogue on AI in health
The policy dialogue centred on the leadership and governance considerations needed for responsible AI adoption. Subsequent workshops focused on practical applications, regional experience and priority use cases.
From capability to context: reflections on the UN’s Preliminary Scientific Report on Artificial Intelligence
AI governance will depend less on building increasingly capable systems than on strengthening the institutions responsible for deploying them wisely, writes Vishnu Narayan.
Ping An Good Doctor unveils 11 health longevity centers across China
The company has additional launched a Longevity Management Ecosystem Alliance, designed to shift the company's health offering from reactive treatment toward earlier risk identification and intervention.
When public health becomes predictive
Healthcare is shifting from treating illness to continuously inferring risk, raising urgent governance questions, writes HealthTechAsia's Vishnu Narayan.